Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
Top Cited Papers
Open Access
- 1 May 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (9) , 1111-1118
- https://doi.org/10.1086/374337
Abstract
We prospectively evaluated the efficacy and toxicity of intravenously administered colistin in 35 episodes of ventilator-associated pneumonia (VAP) duKeywords
This publication has 39 references indexed in Scilit:
- Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatinThorax, 2000
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unitIntensive Care Medicine, 1996
- Nosocomial Acquisition of Multiresistant Acinetobacter baumannii: Risk Factors and PrognosisClinical Infectious Diseases, 1995
- Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patientsIntensive Care Medicine, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- APACHE IICritical Care Medicine, 1985
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976